The 2014 Breast Cancer Symposium is a 2 1⁄2-day multidisciplinary symposium that features presentations on the latest multidisciplinary research from selected theme-based translational and clinical abstracts, as well as related educational sessions. This Symposium offers an opportunity for clinically relevant, in-depth discussions of how and when to translate new findings into patient care and how to be more selective about breast cancer therapy. The American Society of Breast Disease (ASBD), American Society of Breast Surgeons, American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), National Consortium of Breast Centers, Inc. (NCBC, Inc.), and Society of Surgical Oncology (SSO) are cosponsoring this event.
Accreditation and Designation Statement
The American Society of Clinical Oncology (ASCO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This live activity has been approved for a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All nonphysician attendees are welcome to submit a request for a Certificate of Participation, through the submission process, which may enable nonphysicians to apply their Breast Cancer Symposium participation toward re-licensure.
Any questions related to CME may be directed to ASCO Staff at firstname.lastname@example.org or 571-483-1403.
The 2014 Breast Cancer Symposium seeks to provide an opportunity for members of the oncology community to discuss major developments in breast cancer treatment and research in a smaller forum. It is designed to narrow the gap between the care patients with breast cancer receive and the care indicated by current evidence by providing a forum of review and discussion for oncologists.
This Symposium is designed for physicians and researchers including radiologists; medical, surgical, and radiation oncologists; pathologists; and translational-oriented laboratory scientists interested in the prevention, screening, evaluation, and management of breast cancer. This Symposium may also be of benefit to nurses, pharmacists, physician assistants, and other health care professionals involved in clinical care and research in this area.
Upon participation in this activity, attendees will be able to
- Examine advances in clinical and translational breast cancer research
- Evaluate the role of new diagnostic techniques and therapeutic strategies as applied to the care and management of patients with breast cancer
- Implement new practices or revise existing practices based on best-available evidence as presented at the Symposium
This activity was planned in the context of the following ACGME competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement, and Systems-Based Practice.
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and does not necessarily represent the views of the American Society of Clinical Oncology, ASBD, The American Society of Breast Surgeons, ASTRO, NCBC, Inc., SSO, and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.
2014 Breast Cancer Symposium Educational Supporters